Beriont v. Gte Laboratories , 601 F. App'x 937 ( 2015 )


Menu:
  •        NOTE: This disposition is nonprecedential.
    United States Court of Appeals
    for the Federal Circuit
    ______________________
    WALTER J. BERIONT,
    Plaintiff-Appellant
    v.
    GTE LABORATORIES, INC., GTE SERVICE
    CORPORATION, GTE COMMUNICATIONS
    CORPORATION, ALFRED H. BELLOWS,
    Defendants-Appellees
    ______________________
    2014-1424
    ______________________
    Appeal from the United States District Court for the
    District of Massachusetts in No. 1:00-cv-11145-RGS,
    Judge Richard G. Stearns.
    ______________________
    Decided: February 4, 2015
    ______________________
    WALTER J. BERIONT, Maynard, MA, pro se.
    MICHAEL E. JOFFRE, Kellogg, Huber, Hansen, Todd,
    Evans & Figel, PLLC, Washington, DC, for defendants-
    appellees. Also represented by IGOR HELMAN, MELANIE L.
    BOSTWICK.
    ______________________
    Before LOURIE, O’MALLEY, and REYNA, Circuit Judges.
    2                              BERIONT   v. GTE LABORATORIES
    PER CURIAM.
    Walter J. Beriont (“Beriont”) appeals from the deci-
    sion of the United States District Court for the District of
    Massachusetts granting summary judgment that GTE
    Laboratories, Inc., GTE Service Corporation, and GTE
    Communications Corporation (collectively, “GTE”) have at
    all times been a joint owner of U.S. Patent 5,920,802 (the
    “’802 patent”).      See Beriont v. GTE Labs., Inc.,
    No. 00-11145-RGS, 
    2014 WL 585651
     (D. Mass. Feb. 14,
    2014). Because Beriont failed to prove misjoinder of the
    ’802 patent by clear and convincing evidence, we affirm.
    BACKGROUND
    Beriont began working at GTE as an engineer in
    1983. In 1996, Beriont conceived an invention relating to
    improved low frequency power distribution within a cable
    television network. Beriont disclosed this invention to
    Alfred Bellows (“Bellows”), a co-worker at GTE, who
    “constructed, evaluated, and tested” the invention. J.A.
    71. Beriont and Bellows together disclosed the invention
    to GTE in August 1996.
    That same year, Beriont filed an unrelated defama-
    tion action in Massachusetts state court against a co-
    worker and GTE. GTE later terminated Beriont’s em-
    ployment, and Beriont added a wrongful termination
    claim to that action.
    In June 1998, Beriont and Bellows jointly filed a pa-
    tent application through GTE’s patent counsel. Beriont
    and Bellows both signed a Declaration and Power of
    Attorney for Patent Application that was submitted to the
    U.S. Patent and Trademark Office by GTE. J.A. 131.
    Beriont declared that he was the “Second Joint Inventor”
    of the invention described in the application and that he
    appointed GTE attorneys to prosecute the application on
    his behalf. 
    Id.
     Beriont refused to execute a formal as-
    signment agreement. That application issued as the ’802
    BERIONT   v. GTE LABORATORIES                            3
    patent, and is assigned on its face to GTE and lists Be-
    riont and Bellows as co-inventors. See ’802 patent, [73],
    [75]. In November of 1998, while the ’802 application was
    pending, GTE filed a declaratory judgment action in
    Massachusetts state court seeking a declaration that GTE
    was the lawful owner of the patent, as well as specific
    performance ordering Beriont to assign any remaining
    interest in the patent to GTE.
    Then in 2000, while the state court litigation was
    pending, Beriont filed the instant federal action in the
    District Court for the District of Massachusetts, seeking:
    (1) a declaratory judgment that he was the sole inventor
    of the ’802 patent; (2) the removal of Bellows as a co-
    inventor and GTE as assignee; (3) a judgment that GTE
    breached a fiduciary duty owed to Beriont; and (4) a
    judgment of patent infringement against GTE. Beriont v.
    GTE Labs., Inc., No. 1:00-cv-11145-RGS, 
    2012 WL 2449907
    , at *1 (D. Mass. June 27, 2012). The district
    court stayed the case pending the resolution of the state
    court suits. Id. at *2.
    The two Massachusetts state court actions were con-
    solidated, and Beriont and GTE reached a settlement
    agreement on June 13, 2005. The settlement required
    that: (1) GTE would pay Beriont $50,000; (2) GTE and
    Beriont would “agree that they shall be joint owners of
    the patent” in dispute; (3) the parties would “give each
    other mutual releases”; and (4) GTE would provide Be-
    riont with a signed statement that his loss of employment
    did not call into question his “integrity, competence, or
    industry.” J.A. 135–37. Based on the settlement, the
    trial court entered a dismissal nisi in both actions, but
    when the parties failed to submit a formal settlement
    agreement, the state court judge dismissed both actions
    for failure to comply with the nisi order. J.A. 165.
    In 2011, after resolution of the state court suits, the
    district court lifted the stay, and GTE moved for summary
    4                              BERIONT   v. GTE LABORATORIES
    judgment on Beriont’s claims. Beriont, 
    2012 WL 2449907
    ,
    at *2. The court concluded that the ’802 patent was
    jointly owned by GTE (and its successor in interest,
    Verizon Laboratories) and Beriont; that the parties would
    comply with the agreed-upon terms of the settlement; and
    that the joint ownership of the ’802 patent absolved both
    parties of liability for any infringement after the date of
    the settlement. Id. at *3. The court also concluded that
    prior to the settlement date of June 13, 2005, GTE had at
    least “shop-rights” to use the ’802 patent and was there-
    fore not liable for any infringement thereof. Id.
    Beriont appealed to this court, and we affirmed the
    district court’s determination that GTE was not liable for
    infringement after June 13, 2005. Beriont v. GTE Labs.,
    Inc., 535 F. App’x 919, 927 (Fed. Cir. 2013). We vacated
    the judgment of noninfringement for the period preceding
    June 13, 2005, and remanded the case to the district court
    to address the “shop rights” doctrine and GTE’s pre-2005
    activities that fell outside the scope of “shop rights.” Id.
    We also vacated the court’s ruling with regard to Beriont’s
    claim of inventorship because we concluded that the
    district court failed to make explicit findings with respect
    to the inventorship claim. Id.
    On remand, the district court granted summary
    judgment in favor of GTE, concluding that Beriont could
    not prevail on his claim of sole inventorship because “[a]ll
    evidence, even Beriont’s own testimony, establishes the
    contrary.” Beriont, 
    2014 WL 585651
    , at *3. The court
    thus held that there was no infringement by GTE prior to
    June 13, 2015 because its employee Bellows was a right-
    ful co-inventor of the patent and it was undisputed that
    he had assigned his own interest to GTE before the ’802
    patent issued. 
    Id.
     at *4–5.
    Beriont again appealed to this court. We have juris-
    diction pursuant to 
    28 U.S.C. § 1295
    (a)(1).
    BERIONT   v. GTE LABORATORIES                              5
    DISCUSSION
    We apply regional circuit law, here the law of the
    First Circuit, when reviewing a district court’s grant of a
    motion for summary judgment. Teva Pharm. Indus. Ltd.
    v. AstraZeneca Pharm. LP, 
    661 F.3d 1378
    , 1381 (Fed. Cir.
    2001). The First Circuit “afford[s] de novo review to the
    district court’s grant of summary judgment.” Johnson v.
    Gordon, 
    409 F.3d 12
    , 16 (1st Cir. 2005). Summary judg-
    ment is appropriate when, drawing all justifiable infer-
    ences in the nonmovant’s favor, “there is no genuine
    dispute as to any material fact and the movant is entitled
    to judgment as a matter of law.” Fed. R. Civ. P. 56(a);
    Anderson v. Liberty Lobby, Inc., 
    477 U.S. 242
    , 255 (1986).
    Inventorship is a question of law, which we review
    without deference. Ethicon, Inc. v. U.S. Surgical Corp.,
    
    135 F.3d 1456
    , 1460 (Fed. Cir. 1998). We review the
    district court’s underlying findings of fact for clear error.
    
    Id.
     Because the issuance of a patent creates a presump-
    tion that the named inventors are the true and only
    inventors, 
    id.,
     the burden of showing misjoinder or non-
    joinder of inventors is a heavy one and must be proved by
    clear and convincing evidence, Hess v. Advanced Cardio-
    vascular Sys., Inc., 
    106 F.3d 976
    , 980 (Fed. Cir. 1997)
    (citing Garrett Corp. v. United States, 
    422 F.2d 874
    , 880
    (Ct. Cl. 1970)). The moving party “must also show that
    the persons to be removed did not contribute to the inven-
    tion of any of the allowed claims.” Univ. of Pittsburgh v.
    Hedrick, 
    573 F.3d 1290
    , 1297 (Fed. Cir. 2009).
    Beriont argues that the district court erred in grant-
    ing summary judgment because witness credibility was
    central to the court’s determination and summary judg-
    ment is not the appropriate avenue for weighing credibil-
    ity. Beriont also argues that Bellows could not have been
    an inventor because he did not have the knowledge or
    understanding to contribute to the conception of the
    invention of the ’802 patent. GTE responds that the court
    6                              BERIONT   v. GTE LABORATORIES
    properly granted summary judgment because Beriont
    offered no credible evidence that he is the sole inventor of
    the ’802 patent. Specifically, GTE argues that the only
    evidence offered by Beriont is the testimony of Beriont
    himself, and this alone is insufficient as a matter of law.
    According to GTE, all other evidence confirms Bellows’s
    status as a legitimate joint inventor.
    We agree with GTE that the district court properly
    granted summary judgment because Beriont failed to
    prove misjoinder by clear and convincing evidence. The
    ’802 patent lists both Bellows and Beriont as inventors,
    and the inventors named on an issued patent are pre-
    sumed to be correct. Ethicon, 
    135 F.3d at 1460
    . Beriont
    was thus required to prove misjoinder by clear and con-
    vincing evidence, and he failed to present evidence suffi-
    cient to raise a material issue of fact.
    The only evidence that Beriont has offered to support
    his sole inventorship claim is his personal testimony that
    he disclosed the invention to Bellows and that Bellows
    constructed and tested the disclosed invention. However,
    Beriont’s own testimony is insufficient, as we have gener-
    ally required that an inventor’s testimony regarding
    conception of an invention be corroborated. Univ. of
    Pittsburgh, 
    573 F.3d at 1298
    . We have no way in this
    case to corroborate Beriont’s account of the events that led
    to the ’802 patent, and, as a result, it is not possible to
    make “a sound determination of the credibility of the
    inventor’s story.” Price v. Symsek, 
    988 F.2d 1187
    , 1195
    (Fed. Cir. 1993). The court thus did not err in concluding
    that Beriont failed to raise a material issue of fact. We
    have considered Beriont’s remaining arguments and
    conclude that they are without merit.
    CONCLUSION
    Because it is undisputed that Bellows properly as-
    signed his rights in the ’802 patent to GTE in 1998, GTE
    has been a co-owner of the patent since that time and
    BERIONT   v. GTE LABORATORIES                           7
    cannot be liable for infringement. See 
    35 U.S.C. § 262
    (“[E]ach of the joint owners of a patent may make, use,
    offer to sell, or sell the patented invention within the
    United States, or import the patented invention into the
    United States, without the consent of and without ac-
    counting to the other owners.”) The district court’s grant
    of summary judgment to GTE is therefore affirmed.
    AFFIRMED